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The existence of multipotent progenitor populations in the adult
forebrain has been widely studied. To extend this knowledge to
the adult spinal cord we have examined the proliferation, dis-
tribution, and phenotypic fate of dividing cells in the adult rat
spinal cord. Bromodeoxyuridine (BrdU) was used to label di-
viding cells in 13- to 14-week-old, intact Fischer rats. Single
daily injections of BrdU were administered over a 12 d period.
Animals were killed either 1 d or 4 weeks after the last injection
of BrdU. We observed frequent cell division throughout the
adult rodent spinal cord, particularly in white matter tracts
(5–7% of all nuclei). The majority of BrdU-labeled cells colocal-
ized with markers of immature glial cells. At 4 weeks, 10% of
dividing cells expressed mature astrocyte and oligodendroglial
markers. These data predict that 0.75% of all astrocytes and
0.82% of all oligodendrocytes are derived from a dividing pop-
ulation over a 4 week period. To determine the migratory nature
of dividing cells, a single BrdU injection was given to animals
that were killed 1 hr after the injection. In these tissues, the
distribution and incidence of BrdU labeling matched those of
the 4 week post injection (pi) groups, suggesting that prolifer-
ating cells divide in situ rather than migrate from the ependymal
zone. These data suggest a higher level of cellular plasticity for
the intact spinal cord than has previously been observed and
that glial progenitors exist in the outer circumference of the
spinal cord that can give rise to both astrocytes and
oligodendrocytes.
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Using 3H-thymidine as a mitotic marker, Adrian and Walker
(1962) labeled a population of dividing cells in the intact adult rat
spinal cord. Labeled cells had a limited life span beyond 1 week,
suggesting that dividing cells play a limited role in the adult spinal
cord. In 1983, a glial progenitor, the O-2A, was cultured from the
neonatal optic nerve that retained the ability to differentiate into
astrocytes or oligodendrocytes in vitro (Raff et al., 1983). Since
their discovery, these cells have been used extensively as a trans-
plantable source of myelinating cells in models of dysmyelinating
diseases and trauma (Warrington et al., 1992; Laeng et al., 1996;
Espinosa de los Monteros et al., 1997; Franklin and Blakemore,
1997; Hammang et al., 1997). Until 1997, however, no data ex-
isted regarding the location and frequency of the O-2A cell
(GPC) in situ. In 1997, Reynolds and Hardy showed that cells
expressing immature glial markers persisted in the adult rat
cerebral cortex. Gensert and Goldman (1997) showed that a
dividing population of cells resides in the subcortical white matter
and occasionally gives rise to oligodendrocytes. These cells can
differentiate into mature oligodendrocytes but do not appear to
migrate in the intact or injured adult brain (Gensert and Gold-
man, 1997).
Recently, there has been considerable attention focused on the
existence of an adult stem cell. In vitro and in vivo experiments
have shown that cells exist in the intact adult brain that are
self-propagating and capable of producing all of the major neu-
ronal phenotypes. In the spinal cord, adult stem cells can be
isolated, expanded, and differentiated in vitro (Weiss et al., 1996;
Shihabuddin et al., 1997). The anatomical location and morphol-
ogy of these cells in vivo have not been determined. Evidence
suggests that a stem-like cell can be localized in or near the
ependymal layer of the brain and spinal cord (Morshead et al.,
1994; Garcia-Verdugo et al., 1998; Chiasson et al., 1999; Doetsch
et al., 1999; Johansson et al., 1999).
In the present experiments, we sought to quantitatively exam-
ine cell proliferation in the intact adult rat spinal cord and
determine patterns of migration and the degree of differentiation
of mitotically active cells. The existence of spinal glial progenitors
and stem cells in the adult has been determined by several in vitro
experiments; however, the activity, location, and role these cells
play in vivo have not been adequately described. Work by Adrian
and Walker (1962) suggests that these cells are quiescent and
make little contribution to mature neural phenotypes in the adult
spinal cord. In the present study, we used bromodeoxyuridine
(BrdU) to label dividing cells and triple epitope immunohisto-
chemistry to determine their phenotypic fate. The data indicate
that significant cell division occurs in the adult and that a clear
medial to lateral gradient of cell division exists. BrdU-
incorporating cells primarily persist as immature glial progenitors
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that may be bipotent. Specifically, unlike glial progenitors de-
scribed for the brain, these cells express mature oligodendrocyte
and astrocyte markers after 4 weeks.
MATERIALS AND METHODS
Experimental groups. Male Fischer-344 albino rats (n 5 36; Harlan
Sprague Dawley, Indianapolis, IN) were used in this experiment. The
animals were 13–14 weeks of age and weighed between 260 and 300 gm
at the start of the experiment. All animals were housed in pairs in a large,
well-lit laboratory controlled for temperature (21°C) and maintained
with a daily photoperiod of 12 hr of light between 6:00 A.M. and 6:00
P.M. Each animal had ad libitum access to food and water and was fed on
a complete and balanced standard laboratory diet (Teklad 4% rat diet
7001; Harlan Teklad, Madison, WI). Anesthesia was induced by an
intramuscular injection consisting of 44 mg/kg ketamine (Ketaset, 100
mg/ml; Bristol Laboratories, Syracuse, NY), 4 mg/kg xylazine (Rompun,
20 mg/ml; Miles Laboratories, Shawnee, KS), and 0.75 mg/kg of
acepromazine maleate (10 mg/ml; TechAmerica Group, Elwood, KS)
diluted in 0.9% sterile saline.
Bromodeoxyuridine injection paradigms. In Experiment 1, 16 animals
were given a single injection of BrdU (50 mg/kg i.p., Sigma, St. Louis,
MO) and anesthetized 1 or 24 hr, 5 or 7 d after injection as above (n 5
4 each time point). In Experiment 2, 20 animals received one intraperi-
toneal injection of BrdU (50 mg/kg; Sigma) each day for 12 d. At 14 d
after the first intraperitoneal injection, half of the animals (n 5 10) were
anesthetized deeply and perfused intracardially with 4% paraformalde-
hyde in 100 mM phosphate buffer, pH 7.4. Four weeks after the final
injection, a second group (n 5 10) was anesthetized and perfused as
above. Spinal cords were removed, post-fixed over 7 d in 4% parafor-
maldehyde, and transferred to 0.32 M sucrose for cryopreservation.
Tissue processing. Spinal cords were cut into 3 mm coronal segments
and embedded in cryomolds (Fisher Scientific, Pittsburgh, PA) with
O.C.T. mounting medium (Tissue Tek, Torrance, CA). Blocked spinal
cord segments were stored frozen at 270°C until sectioned coronally on
a cryostat (Jung Frigcut 2800E; Leica, Nussloch, Germany) at 40 mm and
stored on slides at 220°C. Slides representative of all groups were
selected for both BrdU immunohistochemistry and triple immunofluo-
rescence labeling.
Immunohistochemistry. For the stereological quantitation of BrdU-
labeled cells, cryostat sections were stained for diaminobenzadine
(DAB) immunohistochemistry. Specifically, sections were pretreated
with 50% formamide in 23 SSC for 2 hr at 65°C; followed by 15 min in
23 SSC, 30 min in 2 N HCl at 37°C, 10 min in 0.1 M borate buffer, and
six 15 min rinses in Tris-buffered saline (TBS), pH 7.5. Nonspecific
labeling was blocked with TBS 1 0.1% Triton X-100 and 3% normal
donkey serum for 30 min. A monoclonal mouse antibody against BrdU
(1:400; Boehringer Mannheim, Indianapolis, IN) was incubated with the
tissue for 2 d at 4°C. After primary antibody incubation, sections were
quenched with 0.6% H2O2 in TBS for 30 min in the dark. Tissue was
rinsed in TBS before incubation with secondary antibody. A polyclonal
donkey a mouse IgG was applied for 1 hr at room temperature (Accurate
Chemicals, Westbury, NY; 1:200 in TBS). Sections were then rinsed
three times in TBS for 15 min both before and after a 1 hr incubation
with avidin–biotin complex (ABC-Elite; Vector Laboratories, Burlin-
game, CA). BrdU labeling was then visualized using DAB (0.25 mg
DAB, 0.009% H2O2, and 0.04% NiCl in TBS) for 9 min. DAB incubation
was terminated by rinsing in tap water, and slides were then dehydrated
through alcohols and coverslipped.
Immunofluorescence. Sections were processed for multiple markers to
determine the cellular phenotype of BrdU-labeled nuclei. Primary anti-
bodies were chosen that recognize immature and mature astrocytes
(S-100b polypeptide), immature neurons (b-tubulin, TUJ1), mature neu-
rons [neuronal nuclear antigen clone A60 (NeuN)], mature astrocytes
[glial fibrillary acidic protein (GFAP)], mature oligodendrocytes (RIP),
and immature/mature astrocytes and oligodendrocytes [adenomatous
polyposis coli tumor suppresser gene (APC)] (Boyes et al., 1986; Fried-
man et al., 1989; Lee et al., 1990; Jhaveri et al., 1992; Bhat et al., 1996;
Wolf et al., 1996; Sarnat et al., 1998). The antibody recognizing APC is
directed against the N-terminal segment of APC and is specific for glial
cells (Calbiochem, La Jolla, CA). This antibody does not show cross-
reactivity with neurons, as has been reported with antibodies directed
against the C terminus of APC or by in situ hybridization (Senda et al.,
1998; Brakeman et al., 1999). Cryostat sections (40 mm) were pretreated
for BrdU detection as described above. Three compatible primary anti-
bodies were applied together for 2 d at 4°C in TBS 1 0.1% Triton X-100
1 5% donkey serum. The following primary antibodies were used at the
following concentrations: rat aBrdU (1:100; Accurate Chemicals), rabbit
aS-100b (1:10,000; Swant, Bellinzona, Switzerland), mouse aNeuN (1:
10; clone A60; Dr. R. Mullin, Salt Lake City, UT), rabbit aGFAP
(1:1000; Dako, Carpinteria, CA), mouse aAPC (1:500; Calbiochem), and
mouse aRIP (supernatant, 1:20; Hybridoma Bank, Iowa City, IA),
mouse aNG2 (1:500; gift of Dr. William Stallcup, Burnham Institute, La
Jolla, CA), mouse aRECA-1 (1:10; Serotec, Oxford, UK). Sections were
rinsed twice in 0.1 M TBS, pH 7.5, and once in 0.1 M TBS pH 7.5 1 0.1%
Triton X-100 for 15 min before application of secondary antibodies. The
following secondary antibodies were applied in 0.1 M TBS, pH 7.5, and
0.1% Triton X-100, each at a concentration of 1:250 for 2 hr in the dark:
donkey a rat IgG conjugated to FITC (1:250; Jackson ImmunoResearch,
West Grove, PA), donkey a mouse IgG conjugated to biotin (1:250;
Jackson ImmunoResearch), and donkey a rabbit conjugated to CY5
(1:250; Jackson ImmunoResearch). Incubation with secondary antibod-
ies was followed by three rinses (15 min) in TBS. Visualization of one
primary antibody was enhanced by incubation with streptavidin conju-
gated with Texas Red in TBS at a concentration of 1:250 for 1 hr.
Streptavidin incubation was also followed by three rinses (15 min) in
TBS. Slides were then immediately coverslipped using polyvinyl alcohol-
1,4 diazabicyclo[2.2.2]octane and then kept in the dark at 4°C until
analysis.
Criteria for microscopic analysis of BrdU labeling. BrdU incorporation is
used as a marker for mitotically active cells. Two basic criteria were
established for proper interpretation of BrdU immunohistochemical
labeling. The first criterion was to establish that the BrdU staining was
located in the nucleus. At the light microscopic level, the presence of
BrdU labeling was determined to be nuclear by alternating between
standard light microscopy to clearly observe the DAB reaction product
followed by differential interference contrast optics to visualize the
nuclear compartment of cells. By alternating between these settings,
BrdU labeling could be localized to the nucleus. In the case of fluorescent
images, the nuclear stain 49,6-diamidino-2-phenylindole (DAPI) was
applied. BrdU immunofluorescent labeling was compared to that of
DAPI to ensure nuclear localization. The second criterion for a BrdU
profile to be considered for quantification is the morphology of the DAB
reaction product. Only uniformly labeled nuclei were considered for
inclusion. BrdU nuclei were excluded from the study if they exhibited
punctate staining in part of the nucleus or the DNA appeared to be
condensed. One exception is in the case in which BrdU immunoreactivity
was detected throughout the nucleus, but the intensity was higher at the
periphery of the nucleus compared to the center. This is thought to
represent an artifact resulting from decreased antibody penetration to the
center of the nucleus.
Quantification of proliferating cells. The total number of BrdU-positive
cells per 40 mm section was determined from coronal sections taken from
segments C7, T8, and L2 (Fig. 1 A). Cells were counted using a template
that was overlaid onto coronal sections. The template divides the spinal
cord into concentric circles (annuli) and quadrants (sectors) (Fig. 1 B,C).
The template was superimposed onto BrdU-labeled (DAB) spinal sec-
tions with the aid of a mechanical stage attached to an Olympus
(Melville, NY) BH-2 microscope and Dage (Michigan City, IN) MTI
CCD-300TIFG video camera. Cell counts were recorded using Stereo
Investigator Software (MicroBrightfield, Colchester, VT), which allowed
the stage to be moved accurately between template regions under high
magnification. Where the template met the outer edge of the spinal cord,
the sector or annulus was closed by tracing the outer circumference of the
spinal cord just medial to the pial layer (Fig. 1 D). A corrected area was
calculated for template regions that were manipulated in this manner.
BrdU-labeled nuclear counts were presented as either (1) cell density
defined as the number of BrdU-labeled nuclei per area sampled or (2) a
labeling index defined as the percentage of all nuclei in each region that
immunolabeled for BrdU. Cell density was calculated by dividing the
number of cells counted per annulus or sector by the measured area of
the template region. Cell density per template area was then extrapo-
lated to the number of cells per cubic millimeter of tissue. A labeling
index was calculated by taking the total number of BrdU-immunoreactive
cells per region and dividing it by the total number of DAPI-labeled
nuclei from the corresponding template region. Representative sections
of the three spinal levels were chosen by an independent observer for
analysis (minimum of three sections per spinal level with a separation of
200 mm) based on the structure of the gray matter. Nuclear counts were
performed by an additional investigator. The total number of BrdU-
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positive cells within the ependymal layer of the central canal was counted
separately; pial cells were excluded from counting.
Quantification of immunofluorescent images. Multiple label immunoflu-
orescent images were collected and quantified using confocal microscopy
(MRC 1000; Bio-Rad, Hercules, CA; Carl Zeiss, Thornwood, NY).
Single confocal plane images of BrdU or phenotype markers (see above)
were collected and combined to determine label colocalization. Counts
were made by dividing the annulus template into two regions: (1) a
medial annulus (,600 mm from the central canal) and (2) an outer
annulus (.600 mm from the central canal). As before, ependymal and
pial cells were not included in this analysis. A cell was counted as an
astrocyte or oligodendrocyte if a well-defined BrdU-labeled nucleus was
associated with an immunopositive (e.g., GFAP, RIP, S100-b etc.) cell
body. The complete cell nucleus was followed through the z-axis, and
only cells with a well-circumscribed, immunopositive cell body were
considered positive for a particular phenotype. A total of 100 BrdU cells
were randomly counted from at least four sections from each of the
medial and outer annuli.
Estimation of nuclear, astrocytic, and oligodendrocyte labeling indexes.
The total number of nuclei per region was estimated from three animals
(four sections each) by counting DAPI-labeled nuclei using the templates
described above. Because of the high number of nuclei, the indicator
fractionator method was used. The total number of astrocytes and
oligodendrocytes from three animals (four sections each) was estimated
by counting all APC/GFAP2 and APC/GFAP1 cells using the tem-
plates described above. A nuclear index was derived by dividing the
number of BrdU-labeled nuclei (counted as above) by the total number
of nuclei for each region analyzed. The labeling index for BrdU-labeled
astrocytes and BrdU-labeled oligodendrocytes was calculated by dividing
the number of BrdU1/APC1/GFAP2 or BrdU1/APC1/GFAP1 cells
by the respective total.
Data analysis. Differences among experimental groups were evaluated
by a one-way ANOVA. Comparisons were made between the 1 d and 4
week group for each template region examined and for the total number
of cells per section, the percentage of total BrdU or the percentage of
total nuclei between the cervical, thoracic, and lumbar regions. A Tukey–
Kramer post hoc analysis was used for follow-up tests of between-group
differences when the overall F was found to be significant. For all
statistical analyses, significance was accepted at a p value of 0.05.
RESULTS
Distribution, migration, and cell cycle of
BrdU-incorporating cells
To determine where BrdU incorporation was most frequent and
to assess whether BrdU-incorporating cells undergo migration,
we injected a single dose of BrdU into animals that were killed at
1 hr or 1, 5, or 7 d postinjection (pi) (Experiment 1). BrdU is
incorporated into the DNA of cells undergoing S-phase. The 1 hr
pi time point labels cells that are undergoing DNA replication
and do not have time to migrate from the site of incorporation. At
this time point, cells were found predominantly as single cell
profiles (Fig. 1E). BrdU-labeled cells were found most commonly
in the outer circumference of the gray and white matter. By 1 d pi,
many BrdU-labeled cells were found in clusters of two or four
cells, indicating cell division had taken place (Fig. 1F) and that
BrdU incorporation remains detectable after multiple cell
divisions.
For quantification of Experiment 1, the distribution of BrdU-
labeled cells was broken down into ependymal, medial (,600 mm
from the central canal), and outer (.600 mm from the central
canal) spinal cord compartments. At 1, 5, and 7 d pi, the total
number of BrdU-labeled cells per section increased. Because the
bioavailability of BrdU persists for only 2 hr pi (Table 1), an
increase in the number of BrdU-labeled cells indicates cell divi-
sion. There was an increase in BrdU-incorporating cells between
1 hr (4.1 nuclei per section) and 7 d (9.3 nuclei per section) of
.100%, indicating that the doubling time of spinal cord progen-
itors is likely between 5 and 7 d. This cell-doubling time indicates
a long cell cycle length. However, without multiple labeling (e.g.,
BrdU followed by 3H-thymidine) of nuclei, the contribution of
cell death cannot be ruled out. If significant cell death of BrdU-
incorporating cells occurs, then cell cycle length may be overes-
timated by these data. At all time points, there was a gradient of
BrdU-labeled cells with almost none residing in the ependymal
layer, few in the medial annulus, and many in the outer annulus.
Interestingly, cells do not appear to migrate between the medial
and outer annuli during this period. These single pulse measure-
ments can be compared to Experiment 2, in which animals were
injected with BrdU once a day for 12 d and killed at 1 d or 4 weeks
after the last injection (Table 1). Comparison of these experi-
mental groups reveals that the incidence of BrdU-incorporating
cells after a single BrdU injection closely matches the distribu-
Figure 1. Quantitative method for counting BrdU-positive nuclei in the
intact spinal cord. Coronal sections (40 mm) from C7, T8, and L2 were
selected for quantitation and immunohistochemically labeled for BrdU
(A). Electronic templates that divided the spinal cord into concentric
annuli (B) and radial sectors (C) were overlaid onto stained sections.
With the aid of an image analysis system, the perimeters of the templates
were delineated by electronically circumscribing the outer circumference
of each tissue section (D). The limit was drawn just beneath the pial
surface. All BrdU-positive nuclei were counted, and the area of each
region was calculated after the regions were delineated. BrdU-labeled
cells at the ependymal layer of the central canal were counted indepen-
dently. BrdU distribution and cell migration was determined in a group of
animals, where a single injection of BrdU was given followed by killing at
1 hr or 1 day after injection (E, F ). Three consecutive 40 mm sections from
a representative animal were traced at the level of T8. Dots indicate the
presence of a BrdU-labeled nucleus. Each section and corresponding
nuclei are represented as a separate color. At 1 hr pi most BrdU-labeled
cells are found as single nuclear profiles, and nuclei are distributed in the
medial and outer circumference of the spinal cord (E). At 1 day pi, the
number of BrdU-labeled nuclei increases, and many of the nuclear profiles
are located in clusters of two (arrows) and four (arrowhead) nuclei,
indicating cell division.
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tions seen at 1 d or 4 weeks after the last of 12 daily BrdU
injections (Table 1). Collectively these data show that cell divi-
sion at the ependymal layer of the central canal is rare and that
the pattern of mitotic cells does not change, indicating limited
migration between medial and outer annuli after cell division.
Morphological appearance of BrdU-labeled nuclei
BrdU-labeled nuclei within the spinal parenchyma at all levels
could be separated into two distinct morphologies. First, elon-
gated or ellipsoid, small nuclei were primarily associated with
radial elements in the spinal white matter (Fig. 2A). Secondly, a
less common form was more rounded, large nuclei not typically
associated with radial elements (Fig. 2B). Whereas the majority
of cells were found in white matter of the outer annuli, one gray
matter region, the substantia gelatinosa, contained numerous
BrdU-positive nuclei (Fig. 2C). Dividing cells were also found in
the ependymal layer surrounding the central canal (Fig. 2D);
however, this was a rare event. The presence of labeled cells near
the central canal indicates that cell division in this population can
be detected with the current labeling protocol. Labeled cells in
the pial layers were also noted (Fig. 2E), but their numbers were
low and not included in the quantitative assessments. The distri-
bution and morphological appearance of BrdU labeling were
similar among all three spinal levels examined.
Quantitative assessment of BrdU distribution
(Experiment 2)
Repeated pulses of BrdU resulted in many BrdU-labeled nuclei
per section. For example, in the cervical spinal cord, an average of
141 6 14 and 133 6 7 BrdU-incorporating nuclei were labeled per
40-mm-thick section at the 1 d and 4 week time points, respec-
tively. These raw counts were used to calculate labeling indexes as
described in Materials and Methods. The annulus template was
used to count cells at 200 mm intervals starting at the central
canal. Results of the radial analysis of the cervical spinal cord are
presented diagramatically in Figure 3. The data confirm the
qualitative observation that cell densities are greatest near the
outer circumference of the spinal cord. This was true for all three
spinal levels. For example, in the thoracic cord 1 d after the last
BrdU injection, the density of BrdU cells ,200 mm from the
central canal is 525 6 170 cells/mm3 or 0.59% of all nuclei. In
medial regions of this level (600–800 mm from the central canal),
the cell density is 1975 6 536 cells/mm3 or 5.4% of all nuclei.
Interestingly, cell densities at the various anatomical locations are
very similar between the 1 d and 4 week pi time points, suggesting
that BrdU-incorporating cells are not lost during this time period.
Furthermore, radial migration of cells is not appreciable. When
the cell densities are analyzed according to the sector template,
Figure 2. Immunohistochemical staining for BrdU in the adult cervical
spinal cord. Photomicrographs are taken from 1 d after the last of 12 daily
BrdU injections. BrdU-labeled nuclei were most commonly found in the
outer white matter where they typically exhibited small, ellipsoid nuclei
that were associated with radial elements (A, arrows indicate radial ele-
ments, 2003). A less common but distinct nuclear morphology was that of
a rounded, large nucleus not associated with radial elements of the spinal
cord (B, 2003). Dense BrdU labeling was also noted in the gray matter,
particularly in the superficial dorsal horn (C, 1003). The substantia
gelatinosa (delineated by lines) was the only gray matter region where
clusters of BrdU-labeled nuclei were noted (arrowheads). BrdU labeling
was rarely noted in the ependymal layer of the central canal, but occa-
sional clusters of these cells could be detected (D, 4003). BrdU-labeled
pial cells were also noted (E, arrows, 4003). The template maps the
anatomical origin of photomicrographs A–E.
Table 1. Quantification of nuclei after single or multiple injections of BrdU
Average number of BrdU-labeled nuclei per section (% of total BrdU-labeled cells/section)
Experiment 1. Single BrdU injection
Experiment 2. 12 daily
BrdU injections
Time after last BrdU injection 1 hr 1 d 5 d 7 d 1 d 4 weeks
Ependyma 0.0064 (0.2) 0 (0) 0.0069 (0.1) 0.01 (0.1) 1.27 (0.76) 1.3 (0.93)
Medial annulus 1.1 (26.8) 1.7 (31.5) 1.9 (25.0) 2 (21.5) 60.2 (36.0) 42.0 (30.0)
Outer annulus 3.0 (73.0) 3.7 (68.5) 5.7 (75.0) 8.2 (88.2) 105.9 (63.2) 96.5 (69.0)
Total 4.1 5.4 7.6 9.3 167.4 139.8
Experiment 1. Animals are given a single BrdU injection and killed 1 hr or 1, 5, or 7 d later. Experiment 2. Animals are given 12 daily injections of BrdU and killed 1 d or
4 weeks after the last injection. The data illustrate that BrdU incorporation rates are highest in the outer annulus of the spinal cord, whereas ependymal cell labeling is rare.
Because the percentage of BrdU-labeled cells does not change over time, this approach suggests that only limited migration of labeled nuclei occurs.
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no significant differences were noted between dorsal, lateral, or
ventral sectors (Fig. 4). This sector analysis also confirms that cell
populations are stable with regard to distribution between tem-
plate regions and total density over time. This does not rule out
the possibility of limited migration of cells within template re-
gions or small subpopulations of cells migrating between delin-
eated template zones. When BrdU distributions are compared
between spinal levels, however, more BrdU labeling was found in
the outer annuli of C7 or L2 sections when compared to the outer
annuli of T8 (Fig. 5). Overall, the percentage of BrdU labeling in
cervical, thoracic, and lumbar spinal cord is significantly higher in
the outer versus the medial annuli, suggesting that this pattern
exists throughout the spinal cord (Fig. 5).
Quantification of BrdU-positive neurons
TUJ1 and NeuN immunoreactivity were used to assess the num-
ber of dividing neurons. Despite the high density of BrdU label-
ing in the substantia gelatinosa, a careful search for BrdU and
NeuN or TUJ1 colocalization yielded no definitive associations.
Twenty-two sections from 10 animals representing a total of 2200
BrdU-positive cells were examined for colocalization of NeuN
and BrdU in the spinal gray matter. In several instances BrdU
nuclei were intimately associated with small neurons in the su-
perficial dorsal horn, but confocal microscopy revealed that these
nuclei likely belonged to closely associated, or satellite cells.
Therefore, no evidence for neurogenesis could be found in this or
any other region of the spinal gray matter.
Quantification of BrdU-positive glial cells
Several glial-associated markers were chosen to classify BrdU-
labeled glial cells. The presence of glial progenitor cells was
determined by colocalization with the proteoglycan marker NG2.
Immature and mature astrocytes were identified by two separate
methods: expression of S-100b or the colocalization of APC and
GFAP (APC/GFAP1). Astrocytes were morphologically distin-
guished from other glia by their limited cytoplasm and small
nucleus. The presence of BrdU-incorporating oligodendrocytes
was also detected by two separate methods. APC immunoreac-
tivity in the absence of GFAP colocalization was used to detect
immature or mature oligodendrocytes (APC/GFAP2). Mature
oligodendrocytes were also labeled with the myelin factor RIP.
Oligodendrocytes typically contained a round or oval cell body
with a large nucleus. Microglial cells were labeled with OX-42 and
vascular endothelial cells with RECA.
NG2 was abundantly expressed by BrdU-incorporating cells.
Figure 3. Quantitation of BrdU-labeled nuclei using an annulus tem-
plate. BrdU-positive nuclei were counted using a template that divides the
spinal cord into five concentric annuli consisting of 200 mm steps begin-
ning at the central canal. The number of BrdU-positive nuclei is expressed
as a percentage of the total number of DAPI-labeled nuclei for each
region. All comparisons are corrected for surface area. The index of
BrdU increases from the medial to the outer annuli, indicating a gradient
of cell division. In addition, only a small decrease in BrdU density is
found between the 1 d and 4 week pi time period. This finding indicates
that labeled cells persist for at least 4 weeks. (*p , 0.05 when compared
to the 0–200 mm annulus, †p , 0.05 when compared to the 600–800 mm
annulus.)
Figure 4. Quantitation of BrdU-labeled nuclei using a sector template.
BrdU-positive nuclei were counted using a template that divides the
spinal cord into radial sectors. Dorsal, lateral, and ventral sectors from C7
are compared. The number of BrdU-positive nuclei is expressed as a
percentage of the total number of DAPI-labeled nuclei for each region.
Comparisons are corrected for surface area. No statistical differences
were noted among sectors. This finding indicates that cell division cannot
be modeled by dorsal to ventral gradients. Non-pooled sectors were also
compared, but no statistical differences were found (data not shown).
Figure 5. Comparison of the incidence of BrdU-positive nuclei at all
three spinal segments. The gradient of BrdU-positive nuclei from the
medial to outer annuli described for the cervical cord is also present at
thoracic and lumbar levels. The number of BrdU-positive nuclei is ex-
pressed as a percentage of the total number of DAPI-labeled nuclei for
each region, and comparisons are corrected for surface area. Note that
the concentration of BrdU-labeled cells is initially higher in the outer
annulus of cervical and lumbar versus that of the thoracic cord (†p , 0.05
when compared to the same region and time of the thoracic spinal cord).
Importantly, cells persist at all levels with only a slight decrease in BrdU
number between the 1 d and 4 week time points (*p , 0.01 when
compared to the medial annulus of the same spinal level).
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Glial progenitors were located throughout the spinal cord and
accounted for as much as 70% of the BrdU population (Fig. 6A;
see Fig. 9C). NG2/BrdU-expressing cells tended to decrease in
number between 1 d and 4 weeks pi, but this decrease did not
reach significance (see Fig. 9). Cells expressing NG2 exhibited
three basic morphologies, including a unipolar, bipolar, and a
complex multipolar form. The most abundant NG2 morphology
that also showed incorporation of BrdU was that of the bipolar
cell (Fig. 6B, top). Complex, multipolar cells were found predom-
inantly at the 4 week pi time point, but represented only a small
portion of the BrdU/NG2 cell population (Fig. 6A,B, bottom).
NG2 colabeled with ;70% of cells that incorporated BrdU 1 hr
pi (Fig. 6C). This finding indicates that the majority of dividing
cells have an immature glial phenotype. In particular, NG2 was
the only antigen coexpressed at 1 hr pi.
BrdU-positive astrocytes that colabeled with either S-100b or
APC/GFAP1 were found in all segments of the spinal cord.
Colabeling was not found at the ependymal layer. S-100b-
immunoreactive cells typically had small, oblong nuclei with
limited cytoplasm and were most commonly found in the white
matter of the outer annuli (Fig. 7B; see Fig. 9B). Many of the
S-100b-positive cells had long radial processes (Fig. 7C). Inter-
estingly, the number of cells that react for S-100b remained stable
between 1 d and 4 weeks (see Fig. 9B). Although this marker
reacts with both mature and immature glial cells, APC/GFAP1
colocalization probably indicates a more differentiated cell (Gha-
ndour et al., 1981). By the APC/GFAP1 colocalization criteria,
astrocytes were rarely seen at the 1 d time point, whereas the
number of these cells significantly increased at 4 weeks (see Fig.
9B). At 4 weeks these BrdU-labeled astrocytes accounted for
0.75% of the total APC/GFAP1 population.
Both immature and mature oligodendrocytes were determined
by counting the number of APC/GFAP2 cells that colocalized
with BrdU. These cells exhibited large round cell bodies with
round nuclei (Fig. 8A,C) and were easily distinguished from the
small, ovoid cellular morphology of APC/GFAP1 astrocytes
(Fig. 8A,B). APC-immunoreactive oligodendrocytes were rarely
observed at 1 d pi. Similar to APC-positive astrocytes, these cells
significantly increased in number between 1 d and 4 weeks pi (Fig.
9A). At 4 weeks, these BrdU-labeled oligodendrocytes accounted
for 0.82% of the total APC/GFAP2 population. To determine if
any of these cells could be mature myelinating cells, we also
quantified the number of RIP-immunoreactive cells (Fig. 9A).
Many cells were RIP-immunopositive, and in some instances
these cells were closely associated with myelin profiles (Fig.
8D,E). Together these results suggest that oligodendrocytes born
in the adult spinal cord exhibit a mature phenotype. Electron
microscopy or coloabeling with myelin specific antigens will be
necessary to determine if these BrdU-labeled cells produce
myelin.
A small portion of BrdU labeling was associated with microglial
or microvascular markers (Fig. 9D). OX-42/BrdU-immuno-
reactive microglia and RECA/BrdU-immunoreactive endothelial
cells accounted for ,2% of the total BrdU labeling, and these
populations decreased significantly at 4 weeks. These data indi-
cate that the microglial /endothelial populations are either divid-
ing at a significantly lower rate than other glial populations or that
cell division is much higher and that the BrdU signal is lost
because of dilution.
DISCUSSION
In the brain, glial progenitors have been labeled with NG2 and
are thought to persist throughout adulthood (Levine and Stall-
cup, 1987; Nishiyama et al., 1996; Reynolds and Hardy, 1997;
Keirstead et al., 1998). However, the in vivo proliferation rate of
these cells has not been determined for the adult brain. The
division rate of adult spinal cord progenitors is thought to be low
Figure 6. NG2 colocalization with BrdU in the adult spinal cord. NG2
immunoreactivity was used to classify BrdU-positive cells as glial progen-
itor cells. NG2 immunoreactivity was found throughout the spinal cord
and labeled cells exhibited unipolar, bipolar, and multipolar cell morphol-
ogies in both gray and white matter. NG2 colocalized with BrdU more
commonly than any other immunohistochemical marker. Throughout the
spinal cord BrdU/NG2 colocalized cells were found that did not colabel
with the glial marker APC (A, arrowhead, 1003). Many BrdU/NG2-
colabeled cells were located near the pial layer with processes extending
into this region (A, arrows). These cells were not found near the central
canal. The predominant morphology was that of a bipolar cell (B, top,
4003). At 4 weeks, a small population had complex, multipolar processes
(B, bottom, 4003). These cells did not colocalize with the mature glial
marker APC. At 1 hr after a single pulse of BrdU, most BrdU-labeled
cells colocalized with NG2 (C, 6303). Single confocal sections of each
marker are presented for both NG2-immunoreactive cells.
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(Adrian and Walker, 1962) with increased mitosis after growth
factor stimulation or injury (Bruni et al., 1985; Prayoonwiwat and
Rodriguez, 1993; Frisen et al., 1995; Beattie et al., 1997; McTigue
et al., 1998). Our data provide evidence of an active progenitor
population that persists after postnatal glial cell formation is
thought to have ceased. The current work shows a direct corre-
lation between immature NG2-expressing cells and a proliferative
cell population in the outer annuli (.600 mm from the central
canal) of the adult spinal cord. The data indicate that 0.6–0.7% of
the glial cells in the adult spinal cord incorporate BrdU over a 4
week period and that cell division of glial progenitors is a com-
mon feature of this process.
Persistence of glial progenitors after mitosis in the
spinal cord
Adrian and Walker (1962) demonstrated that a single day of
3H-thymidine injections in the adult mouse (six single injections
given at 4 hr intervals) resulted in 4.35 mitotic profiles per
horizontal section (7 mm) at 24 hr after the first injection. Al-
though many of these cells resembled glial cells morphologically,
only 25% of labeled nuclei persisted longer than 4 d after the first
injection. It was concluded that newborn glial cells were transient
and that a significant glial or neuronal renewal system in the adult
spinal cord does not exist. These data are surprising considering
data in the brain demonstrating glial cell division in adult animals
(Altman, 1963; Hommes and Leblond, 1967; Mares et al., 1975;
Kaplan and Hinds, 1980; McCarthy and Leblond, 1988). In the
present experiments, 12 daily injections of BrdU resulted in over
100 labeled nuclei per cross section (40 mm). In the outer annulus,
this represents up to 8% of the total nuclei. The majority of these
cells incorporate BrdU and coincidentally express NG2, indicat-
ing that these cells are progenitors. One reason why we observe
the persistence of labeled cells not seen in previous studies in the
adult spinal cord may be methodological. Adrian and Walker
(1962) reported a high incidence of pyknotic nuclei in their
studies that might reflect cell death as a result of repeated 3H-
thymidine dosing over 1 d. This result could explain the initially
high incidence of nuclear labeling that was followed by a rapid
loss of labeled cells. Using the current method (single pulses of
BrdU over 12 d), we were able to detect relatively high levels of
cell division and could demonstrate that these cells persist for at
least 1 month. In addition, pyknotic nuclei were very rare.
Glial-restricted progenitors divide more slowly in the
adult spinal cord
The majority of BrdU-labeled nuclei are glial-restricted progen-
itors that express NG2. Interestingly, BrdU/NG2-colabeled cells
exhibit similar morphologies to the three described by Wren et al.
Figure 7. BrdU/S100b colocalization in the adult spi-
nal cord. Confocal microscopy was used to determine
the incidence of BrdU/S100b colocalization. A confo-
cal z-series allows examination of nuclei through their
entire z-axis in 1 mm steps (A, 4003). In this series a
BrdU-positive nucleus (red only) is associated with
S100b immunoreactivity ( green only). These markers
consistently colocalize (red and green merge) through-
out the series (arrowheads). S100b astrocytes (arrow-
head) often exhibited a radial morphology with long
central to lateral processes (B, arrows, 2003). Occa-
sionally BrdU-positive astrocytes had processes that
contained a lumen associated with microvascular ele-
ments (C, arrows, 8003).
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(1992) for O2-A cells in vitro. The predominant form is a bipolar
cell thought to be a proliferative perinatal progenitor. In the
present experiments, the majority of BrdU-labeled cells exhibit
this morphology, indicating that this cell remains mitotically
active in the adult in vivo. We also found BrdU/NG2 colabeled
cells that resembled the unipolar and oligodendrocyte-like mor-
phologies described as adult progenitors. The 1 hr labeling data
(Experiment 1) suggest a long cell cycle of 5–7 d for BrdU-
colabeled NG2 cells that agrees with that measured for adult glial
progenitor cells in vitro (65 6 18 hr; Wren et al., 1992). However,
without multiple labeling of nuclei (e.g., BrdU followed by 3H-
thymidine) the contribution of cell death or asymmetric cell
division cannot be calculated (Takahashi et al., 1996).
Majority of dividing progenitors reside in the outer
circumference of the spinal cord
Our data reveal that there is no statistical difference in the rate of
division or persistence of dividing cells between dorsal, lateral, or
ventral regions. However, there was a striking regional gradient
between the medial and outer aspects of the spinal cord. This
finding does not coincide with a blunt demarcation between gray
and white matter. When the analysis was broken down into annuli
200 mm in width, there was a significant increase between the 800
mm annulus and the 1000 mm annulus. Because both of these
annuli consist primarily of white matter, this finding suggests that
cell division is highest in outer versus more medial white matter
zones.
The results of our single BrdU injection paradigm indicate that
BrdU-labeled cells do not migrate extensively between template
regions. This does not rule out the possibility of limited migration
within the template regions we analyzed. However, this finding
indicates that BrdU-labeled cells do not commonly migrate from
the central canal as previously described for the early postnatal
spinal cord (Fig. 10, I). We have diagrammed two alternative
models that are in part supported by our data. (Fig. 10, II, III). In
model II, a stem cell exists at the ependymal layer that divides
asymmetrically. A daughter cell then migrates to the outer cir-
cumference of the spinal cord where it exists as a bipotent or glial
progenitor and begins to divide more rapidly. This model sepa-
rates the slowly dividing stem cell at the central canal from a
proliferative progenitor that migrates first and then divides in the
outer annuli of the spinal cord. An alternative possibility, model
III, predicts that a glial progenitor and stem cell population may
exist in the outer circumference of the spinal cord where cell
division is more common. This model functionally separates
ependymal cell division from the proliferative zone of the outer
annuli.
Do dividing adult spinal cord cells form
mature phenotypes?
Recently, it has been postulated that stem cells in the brain
express GFAP (Doetsch et al., 1999). In the present study we did
not observe GFAP colocalization at the ependymal layer. How-
ever, ;10% of the BrdU-labeled cells exhibited a radial morphol-
ogy and expressed the glial marker S-100b. Interestingly, a shift in
cell distribution did not occur between 1 d and 4 weeks after the
last BrdU injection. These data do not delineate between a stable,
maturing astrocytic population or one that is transiently express-
ing an astrocytic phenotype. In addition, it has been shown that
intrafasiculur oligodendrocytes express S-100b (Korr et al.,
1994). Future experiments are required to determine the matu-
rity of these cells and the role they may play in the spinal cord.
Gensert and Goldman (1996) have proposed that clonal popu-
lations of dividing progenitors exist in the subcortical white mat-
ter of the adult forebrain. Virally labeled cells were initially
distributed uniformly within the subcortical white matter, but by
30 d cells were located in clusters, indicating continued division
with limited migration. This pattern is strikingly similar to our
results in the outer annuli of the adult spinal cord. In Gensert and
Goldman’s studies, nearly 20% of labeled cells expressed the
mature oligodendrocyte marker RIP, but none expressed astro-
cytic markers. The authors concluded that a progenitor existed
with the potential for myelin formation. In contrast to the sub-
cortical white matter, our findings suggest that adult spinal cord
glial progenitors produce both astrocytes and oligodendrocytes.
S-100b/BrdU-colabeled cells were detected at 1 d pi, and this
population was maintained at 4 weeks post pi, indicating the
continued presence of dividing astrocytes. Importantly, no evi-
Figure 8. APC, GFAP, and RIP colocalization with
BrdU in the adult spinal cord. APC and GFAP immu-
noreactivity were used to classify BrdU-positive cells
into immature oligodendrocytes or astrocytes. APC
immunoreactivity was found throughout the spinal
cord, especially in the white matter where astrocytes
and oligodendrocytes were found in radially oriented
chains (A, arrows, 2003). Astrocytes were character-
ized by a small somal size and colocalization with
GFAP (A, arrowhead; B, 8003). Oligodendrocytes
were also detected with this method. Oligodendro-
cytes contained large, rounded cell bodies that did not
colocalize with GFAP (C, 80003). Separate color
channels are presented at the bottom of B and C.
Mature oligodendrocytes were identified by colocal-
ization of BrdU and RIP immunoreactivity (D, arrow-
head, 4003). Confocal microscopy was used to deter-
mine if RIP-positive cell bodies contained BrdU-
positive nuclei (E, 8003). Separate confocal channels
are presented to the right.
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dence for mature astrocytes or oligodendrocytes was observed at
1 d after the last BrdU injection. However, by 4 weeks pi, nearly
5% of dividing cells expressed either mature or immature mark-
ers associated with oligodendrocytes, and 3–5% of the total
BrdU-labeled cells expressed mature astrocyte markers. Thus,
progenitor proliferation could account for a modest turnover of
spinal astrocytes and oligodendrocytes during the life of the rat.
Future experiments are required to determine if the differenti-
ated cells observed here arise from glial restricted progenitor
cells or a combination of astrocyte restricted and oligodendrocyte
restricted progenitors.
Ontogeny of spinal tracts
One possible explanation for the persistent birth of glial cells in
the outer annuli of the spinal cord is the presence of late-
developing axonal tracts (Barres and Raff, 1993, 1994; Burne et
al., 1996). The outer annuli, where BrdU incorporation is highest,
contain the dorsal and ventral spinocerebellar tract (Ashwell and
Zhang, 1992). However, these tracts are complete by postnatal
day 7 (Arsenio Nunes and Sotelo, 1985). Two tracts continue to
develop postnatally for up to 2 weeks, specifically the corticospi-
nal tract and the rubrospinal tract (Kudo et al., 1993). These tracts
travel in distinct regions of the spinal cord (Joosten et al., 1987;
Figure 10. Models of stem cell proliferation and migration in the intact
adult spinal cord. Three models illustrate how dividing stem cells may
give rise to progenitors that migrate and proliferate. Model I corresponds
to early postnatal gliogenesis. The current data suggest that in the adult,
dividing cells are located primarily in the outer circumference of the
spinal cord, and therefore Models II and III more likely reflect adult
gliogenesis in the intact spinal cord.
Figure 9. Quantitation of BrdU-labeled cells in the adult spinal cord. One hundred BrdU-positive cells from at least three sections from spinal levels
C7, T8, and L2 were examined with a confocal microscope. Only nuclei that could be localized to one of the phenotypic markers throughout the z plane
were considered positive. Medial measurements are taken from the medial annulus (0–600 mm from the central canal), and outer measurements are
taken from the outer annulus (.600 mm from the central canal). Cells were counted as oligodendrocytes (A) if they were immunoreactive for RIP/BrdU
or APC/GFAP2/BrdU. At all spinal levels the number of oligodendrocytes was low 1 d after the last BrdU injection, but significantly increased to 5%
at 4 weeks. APC/GFAP1/BrdU-labeled astrocytes followed a similar progression (B) and significantly increased at the 4 week time point. S100b/
BrdU-immunoreactive astrocytes (B) represented a unique population in that their numbers did not significantly increase over time. Note that 1 d after
the last injection, the number of S100b/BrdU-immunoreactive astrocytes in the outer annulus is ;6% and remains stable at 4 weeks (C). The most
abundant population of BrdU-labeled cells were immunoreactive for NG2/BrdU. This population of glial progenitors was ;50–60% of the total
BrdU-labeled cells at 1 d. Although there was a trend toward decreased NG2/BrdU colabeling at 4 weeks, this did not reach statistical significance. A
small portion of BrdU labeling was associated with microglial or microvascular markers (D). OX-42/BrdU-immunoreactive microglia and RECA/BrdU-
immunoreactive endothelial cells accounted for ,2% of the total BrdU, and these populations decreased significantly at 4 weeks. (*p , 0.01 when
compared to the 1 d time point of the same phenotype).
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Antal et al., 1992), but there does not seem to be a higher density
of cell division in either of these regions.
Conclusions
The present study demonstrates that cell division occurs in glial
progenitors throughout the adult spinal cord. Importantly, these
data demonstrate that BrdU-labeled cells persist for at least 4
weeks after dividing and that up to 10% of these cells differen-
tiate into mature astroglia and oligodendroglia. In the future,
experimental manipulation of adult spinal progenitor populations
in vivo should provide a clearer understanding of how these cells
may be induced to proliferate, migrate, and differentiate to pro-
mote repair of the spinal cord.
REFERENCES
Adrian Jr EK, Walker BE (1962) Incorporation of thymidine-H 3 by cells
in normal and injured mouse spinal cord. J Neuropathol Exp Neurol
21:597–609.
Altman J (1963) Autoradiographic investigation of cell proliferation in
the brains of rats and cats. Anat Rec 145:573–591.
Antal M, Sholomenko GN, Moschovakis AK, Storm-Mathisen J, Heiz-
mann CW, Hunziker W (1992) The termination pattern and postsyn-
aptic targets of rubrospinal fibers in the rat spinal cord: a light and
electron microscopic study. J Comp Neurol 325:22–37.
Arsenio Nunes ML, Sotelo C (1985) Development of the spinocerebellar
system in the postnatal rat. J Comp Neurol 237:291–306.
Ashwell KW, Zhang LL (1992) Ontogeny of afferents to the fetal rat
cerebellum. Acta Anat (Basel) 145:17–23.
Barres BA, Raff MC (1993) Proliferation of oligodendrocyte precursor
cells depends on electrical activity in axons. Nature 361:258–260.
Barres BA, Raff MC (1994) Control of oligodendrocyte number in the
developing rat optic nerve. Neuron 12:935–942.
Beattie MS, Bresnahan JC, Komon J, Tovar CA, Van Meter M, Anderson
DK, Faden AI, Hsu CY, Noble LJ, Salzman S, Young W (1997)
Endogenous repair after spinal cord contusion injuries in the rat. Exp
Neurol 148:453–463.
Bhat RV, Axt KJ, Fosnaugh JS, Smith KJ, Johnson KA, Hill DE, Kinzler
KW, Baraban JM (1996) Expression of the APC tumor suppressor
protein in oligodendroglia. Glia 17:169–174.
Boyes BE, Kim SU, Lee V, Sung SC (1986) Immunohistochemical co-
localization of S-100b and the glial fibrillary acidic protein in rat brain.
Neuroscience 17:857–865.
Brakeman JS, Gu SH, Wang XB, Dolin G, Baraban JM (1999) Neuronal
localization of the Adenomatous polyposis coli tumor suppressor pro-
tein. Neuroscience 91:661–672.
Bruni JE, Del Bigio MR, Clattenburg RE (1985) Ependyma: normal and
pathological. A review of the literature. Brain Res 356:1–19.
Burne JF, Staple JK, Raff MC (1996) Glial cells are increased propor-
tionally in transgenic optic nerves with increased numbers of axons.
J Neurosci 16:2064–2073.
Chiasson BJ, Tropepe V, Morshead CM, van der Kooy D (1999) Adult
mammalian forebrain ependymal and subependymal cells demonstrate
proliferative potential, but only subependymal cells have neural stem
cell characteristics. J Neurosci 19:4462–4471.
Doetsch F, Caille I, Lim DA, Garcia-Verdugo JM, Alvarez-Buylla A
(1999) Subventricular zone astrocytes are neural stem cells in the adult
mammalian brain. Cell 97:703–716.
Espinosa de los Monteros A, Zhao P, Huang C, Pan T, Chang R,
Nazarian R, Espejo D, de Vellis J (1997) Transplantation of CG4
oligodendrocyte progenitor cells in the myelin-deficient rat brain re-
sults in myelination of axons and enhanced oligodendroglial markers.
J Neurosci Res 50:872–887.
Franklin RJ, Blakemore WF (1997) Transplanting oligodendrocyte pro-
genitors into the adult CNS. J Anat 190:23–33.
Friedman B, Hockfield S, Black JA, Woodruff KA, Waxman SG (1989)
In situ demonstration of mature oligodendrocytes and their processes:
an immunocytochemical study with a new monoclonal antibody, Rip.
Glia 2:380–390.
Frisen J, Johansson CB, Torok C, Risling M, Lendahl U (1995) Rapid,
widespread, and long-lasting induction of nestin contributes to the
generation of glial scar tissue after CNS injury. J Cell Biol
131:453–464.
Garcia-Verdugo JM, Doetsch F, Wichterle H, Lim DA, Alvarez-Buylla A
(1998) Architecture and cell types of the adult subventricular zone: in
search of the stem cells. J Neurobiol 36:234–248.
Gensert JM, Goldman JE (1996) In vivo characterization of endogenous
proliferating cells in adult rat subcortical white matter. Glia 17:39–51.
Ghandour MS, Labourdette G, Vincendon G, Gombos G (1981) A bio-
chemical and immunohistological study of S100 protein in developing
rat cerebellum. Dev Neurosci 4:98–109.
Hammang JP, Archer DR, Duncan ID (1997) Myelination following
transplantation of EGF-responsive neural stem cells into a myelin-
deficient environment. Exp Neurol 147:84–95.
Hommes OR, Leblond CP (1967) Mitotic division of neuroglia in the
normal adult rat. J Comp Neurol 129:269–278.
Jhaveri S, Erzurumlu RS, Friedman B, Schneider GE (1992) Oligoden-
drocytes and myelin formation along the optic tract of the developing
hamster: an immunohistochemical study using the Rip antibody. Glia
6:138–148.
Johansson CB, Momma S, Clarke DL, Risling M, Lendahl U, Frisen J
(1999) Identification of a neural stem cell in the adult mammalian
central nervous system. Cell 96:25–34.
Joosten EA, Gribnau AA, Dederen PJ (1987) An anterograde tracer
study of the developing corticospinal tract in the rat: three components.
Brain Res 433:121–130.
Kaplan MS, Hinds JW (1980) Gliogenesis of astrocytes and oligoden-
drocytes in the neocortical grey and white matter of the adult rat:
electron microscopic analysis of light radioautographs. J Comp Neurol
193:711–727.
Keirstead HS, Levine JM, Blakemore WF (1998) Response of the oli-
godendrocyte progenitor cell population (defined by NG2 labeling) to
demyelination of the adult spinal cord. Glia 22:161–170.
Korr H, Horsmann C, Schurmann M, Delaunoy JP, Labourdette G
(1994) Problems encountered when immunocytochemistry is used for
quantitative glial cell identification in autoradiographic studies of cell
proliferation in the brain of the unlesioned adult mouse. Cell Tissue
Res 278:85–95.
Kudo N, Furukawa F, Okado N (1993) Development of descending
fibers to the rat embryonic spinal cord. Neurosci Res 16:131–141.
Laeng P, Molthagen M, Yu EG, Bartsch U (1996) Transplantation of
oligodendrocyte progenitor cells into the rat retina: extensive myelina-
tion of retinal ganglion cell axons. Glia 18:200–210.
Lee MK, Tuttle JB, Rebhun LI, Cleveland DW, Frankfurter A (1990)
The expression and posttranslational modification of a neuron-specific
b-tubulin isotype during chick embryogenesis. Cell Motil Cytoskel
17:118–132.
Levine JM, Stallcup WB (1987) Plasticity of developing cerebellar cells
in vitro studied with antibodies against the NG2 antigen. J Neurosci
7:2721–2731.
Mares V, Lodin Z, Jilek M (1975) An estimate of the number of cells
arising by division in mouse cerebral hemispheres from age one to 12
months: an autoradiographic study of DNA synthesis. J Comp Neurol
161:471–482.
McCarthy GF, Leblond CP (1988) Radioautographic evidence for slow
astrocyte turnover and modest oligodendrocyte production in the cor-
pus callosum of adult mice infused with 3H-thymidine. J Comp Neurol
271:589–603.
McTigue DM, Horner PJ, Stokes BT, Gage FH (1998) Neurotrophin-3
and brain-derived neurotrophic factor induce oligodendrocyte prolif-
eration, migration, and myelination in the contused adult rat spinal
cord. J Neurosci 18:5354–5365.
Morshead CM, Reynolds BA, Craig CG, McBurney MW, Staines WA,
Morassutti D, Weiss S, van der Kooy D (1994) Neural stem cells in the
adult mammalian forebrain: a relatively quiescent subpopulation of
subependymal cells. Neuron 13:1071–1082.
Nishiyama A, Lin XH, Giese N, Heldin CH, Stallcup WB (1996) Colo-
calization of NG2 proteoglycan and PDGF alpha-receptor on O2A
progenitor cells in the developing rat brain. J Neurosci Res 43:299–314.
Prayoonwiwat N, Rodriguez M (1993) The potential for oligodendro-
cyte proliferation during demyelinating disease. J Neuropathol Exp
Neurol 52:55–63.
Raff MC, Miller RH, Noble M (1983) A glial progenitor cell that devel-
ops in vitro into an astrocyte or an oligodendrocyte depending on
culture medium. Nature 303:390–396.
Reynolds R, Hardy R (1997) Oligodendroglial progenitors labeled with
the O4 antibody persist in the adult rat cerebral cortex in vivo. J Neu-
rosci Res 47:455–470.
Sarnat HB, Nochlin D, Born DE (1998) Neuronal nuclear antigen
Horner et al. • Progenitors in Adult Spinal Cord J. Neurosci., March 15, 2000, 20(6):2218–2228 2227
(NeuN): a marker of neuronal maturation in early human fetal nervous
system. Brain Dev 20:88–94.
Senda T, Iino S, Matsushita K, Matsumine A, Kobayashi S, Akiyama T
(1998) Localization of the adenomatous polyposis coli tumour sup-
pressor protein in the mouse central nervous system. Neuroscience
83:857–866.
Shihabuddin LS, Ray J, Gage FH (1997) FGF-2 is sufficient to isolate
progenitors found in the adult mammalian spinal cord. Exp Neurol
148:577–586.
Takahashi T, Nowakowski RS, Caviness VS (1996) The leaving or Q
fraction of the murine cerebral proliferative epithelium: a general
model of neocortical neuronogenesis. J Neurosci 16:6183–6196.
Warrington AE, Barbarese E, Pfeiffer SE (1992) Stage specific,
(O41GalC-) isolated oligodendrocyte progenitors produce MBP1 my-
elin in vivo. Dev Neurosci 14:93–97.
Weiss S, Dunne C, Hewson J, Wohl C, Wheatley M, Peterson AC,
Reynolds BA (1996) Multipotent CNS stem cells are present in the
adult mammalian spinal cord. J Neurosci 16:7599–7609.
Wolf HK, Buslei R, Schmidt-Kastner R, Schmidt-Kastner PK, Pietsch T,
Wiestler OD, Bluhmke I (1996) NeuN: a useful neuronal marker for
diagnostic histopathology. J Histochem Cytochem 44:1167–1171.
Wren D, Wolswijk G, Noble M (1992) In vitro analysis of the origin
and maintenance of O-2Aadult progenitor cells. J Cell Biol 116:
167–176.
2228 J. Neurosci., March 15, 2000, 20(6):2218–2228 Horner et al. • Progenitors in Adult Spinal Cord
